RPG Life Sciences Limited (NSEI:RPGLIFE) is looking for M&A. Yugal Sikri, Managing Director said, "A lot of work is going on from back end to front end to have technology adoption so that we are able to increase the speed. We are able to decrease the cost and then be competitive. First is M&As, we have a good cash surplus available to us and we want to deploy that with well thought-out M&A strategy, which is in line with profitable growth, which we have talked about earlier.

One of the pillar for our future is M&A, mergers and acquisitions. We are -- we have, as you rightly mentioned, we have a good surplus now. And we also crafted our M&A strategy.

And we are diligently working on this, maybe 15 to 20 proposals we would have seen in the last 1 year. But we want to be thoughtful when we pursue the M&A target and that war chest which we have. Apart from modernization of the plants and creating new product assets in R&D, it will be deployed in inorganic growth as and when we get the right candidate".